Trial Site Detail

 

Drug:
Imatinib + Sunitinib + Regorafenib
Trial:
GIST: Assessment of Tumor Mutations and TKI Plasma Exposure
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

University Medical Center Groningen

     
Groningen , 9713 GZ
Netherlands

 

Principal Investigator:
 A K Reyners, MD, PhD
Contact:
 A. K. Reyners, MD, PhD +31 50 361 2821 a.k.l.reyners@umcg.nl
Activation Status of this Site:
 Active
Notes about this Site:
University Medical Center Groningen Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.